Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-05-22 14:17:36 UTC |
---|
Update Date | 2023-02-21 17:16:10 UTC |
---|
HMDB ID | HMDB0002108 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Methylcysteine |
---|
Description | Methylcysteine is one of the identified number of bioactive substances in garlic that are water soluble (PMID 16484549 ). It has been suggested that the use of these organosulfur agents derived from garlic could protect partially oxidized and glycated LDL or plasma against further oxidative and glycative deterioration, which might benefit patients with diabetic-related vascular diseases (PMID 15161248 ). It may also exert some chemopreventive effects on chemical carcinogenesis. However, it should be borne in mind that may also demonstrate promotion potential, depending on the organ examined (PMID 9591199 ). Methylcystein is a biomarker for the consumption of dried and cooked beans. |
---|
Structure | InChI=1S/C4H9NO2S/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(2R)-2-Amino-3-(methylsulfanyl)propanoic acid | HMDB | (R)-2-Amino-3-(methylthio)propanoic acid | HMDB | 3-(Methylthio)-L-alanine | HMDB | L-Methylcysteine | HMDB | S-Methyl-L-cysteine | HMDB | (2R)-2-Amino-3-(methylsulfanyl)propanoate | HMDB | (2R)-2-Amino-3-(methylsulphanyl)propanoate | HMDB | (2R)-2-Amino-3-(methylsulphanyl)propanoic acid | HMDB | (R)-2-Amino-3-(methylthio)propanoate | HMDB | 3-(Methylthio)-L-(8ci)alanine | HMDB | Acm-thiopropionate | HMDB | Acm-thiopropionic acid | HMDB | L-Aspartic acid dimethyl ester | HMDB | S-Acetamidomethyl-deamino-cysteine | HMDB | S-Methyl-(9ci)-L-cysteine | HMDB | S-Methyl-cysteine | HMDB | S-Methyl-DL-cysteine | HMDB | S-Methylcysteine | HMDB | S-11C-Methyl-L-cysteine | HMDB | S-Methylcysteine, (DL-cys)-isomer | HMDB | S-Methylcysteine, hydrochloride, (L-cys)-isomer | HMDB | S-Methylcysteine, (L-cys)-isomer | HMDB |
|
---|
Chemical Formula | C4H9NO2S |
---|
Average Molecular Weight | 135.18 |
---|
Monoisotopic Molecular Weight | 135.035399708 |
---|
IUPAC Name | (2S)-2-amino-3-(methylsulfanyl)propanoic acid |
---|
Traditional Name | (2S)-2-amino-3-(methylsulfanyl)propanoic acid |
---|
CAS Registry Number | 1187-84-4 |
---|
SMILES | CSC[C@@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C4H9NO2S/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1 |
---|
InChI Key | IDIDJDIHTAOVLG-GSVOUGTGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cysteine and derivatives. Cysteine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Cysteine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Cysteine or derivatives
- S-alkyl-l-cysteine
- Alpha-amino acid
- D-alpha-amino acid
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Thioether
- Sulfenyl compound
- Dialkylthioether
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Carbonyl group
- Amine
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 122.847 | 30932474 | DeepCCS | [M-H]- | 119.617 | 30932474 | DeepCCS | [M-2H]- | 156.523 | 30932474 | DeepCCS | [M+Na]+ | 131.483 | 30932474 |
Predicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.03 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 9.8452 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.54 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 380.0 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 671.4 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 360.5 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 49.4 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 225.1 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 73.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 274.2 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 273.4 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 786.2 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 666.4 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 52.5 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 759.0 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 206.7 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 236.9 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 591.0 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 394.6 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 287.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Methylcysteine,1TMS,isomer #1 | CSC[C@@H](N)C(=O)O[Si](C)(C)C | 1298.5 | Semi standard non polar | 33892256 | Methylcysteine,1TMS,isomer #2 | CSC[C@@H](N[Si](C)(C)C)C(=O)O | 1385.2 | Semi standard non polar | 33892256 | Methylcysteine,2TMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1412.7 | Semi standard non polar | 33892256 | Methylcysteine,2TMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1384.5 | Standard non polar | 33892256 | Methylcysteine,2TMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1733.0 | Standard polar | 33892256 | Methylcysteine,2TMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1555.3 | Semi standard non polar | 33892256 | Methylcysteine,2TMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1468.1 | Standard non polar | 33892256 | Methylcysteine,2TMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1866.4 | Standard polar | 33892256 | Methylcysteine,3TMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1570.9 | Semi standard non polar | 33892256 | Methylcysteine,3TMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1532.6 | Standard non polar | 33892256 | Methylcysteine,3TMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1610.7 | Standard polar | 33892256 | Methylcysteine,1TBDMS,isomer #1 | CSC[C@@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1536.6 | Semi standard non polar | 33892256 | Methylcysteine,1TBDMS,isomer #2 | CSC[C@@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1634.6 | Semi standard non polar | 33892256 | Methylcysteine,2TBDMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1881.6 | Semi standard non polar | 33892256 | Methylcysteine,2TBDMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1819.3 | Standard non polar | 33892256 | Methylcysteine,2TBDMS,isomer #1 | CSC[C@@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1939.1 | Standard polar | 33892256 | Methylcysteine,2TBDMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1990.8 | Semi standard non polar | 33892256 | Methylcysteine,2TBDMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1907.8 | Standard non polar | 33892256 | Methylcysteine,2TBDMS,isomer #2 | CSC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2006.7 | Standard polar | 33892256 | Methylcysteine,3TBDMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2255.4 | Semi standard non polar | 33892256 | Methylcysteine,3TBDMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2160.7 | Standard non polar | 33892256 | Methylcysteine,3TBDMS,isomer #1 | CSC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2001.3 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Methylcysteine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 10V, Negative-QTOF | splash10-0002-9000000000-e1d92d2a30bee517d754 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 20V, Negative-QTOF | splash10-0002-9000000000-e1d92d2a30bee517d754 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 40V, Negative-QTOF | splash10-0002-9000000000-e1d92d2a30bee517d754 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 10V, Positive-QTOF | splash10-014i-3900000000-5cbf55ce6a100129ce26 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 20V, Positive-QTOF | splash10-00dj-9200000000-db00622b129035e9b4e3 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Methylcysteine 40V, Positive-QTOF | splash10-0002-9000000000-b7d1bbbfc29f4c11b472 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 3.9 +/- 1.9 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.34-0.82 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.35-0.63 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.0796-0.717 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.0177-0.619 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.34-0.82 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0.35-0.63 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB003689 |
---|
KNApSAcK ID | C00000747 |
---|
Chemspider ID | 79551 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | S-METHYL-L-CYSTEINE |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | S-Methylcysteine |
---|
METLIN ID | 6490 |
---|
PubChem Compound | 88180 |
---|
PDB ID | 060 |
---|
ChEBI ID | 45658 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1281351 |
---|
References |
---|
Synthesis Reference | Ma, Chengjun; Yao, Fei; Zhang, Guanyong. Synthesis of S-methyl-L-cysteine. Huaxue Shijie (2003), 44(7), 370-372. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Huang CN, Horng JS, Yin MC: Antioxidative and antiglycative effects of six organosulfur compounds in low-density lipoprotein and plasma. J Agric Food Chem. 2004 Jun 2;52(11):3674-8. [PubMed:15161248 ]
- Rivlin RS: Is garlic alternative medicine? J Nutr. 2006 Mar;136(3 Suppl):713S-715S. [PubMed:16484549 ]
- Fukushima S, Takada N, Hori T, Wanibuchi H: Cancer prevention by organosulfur compounds from garlic and onion. J Cell Biochem Suppl. 1997;27:100-5. [PubMed:9591199 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|